Abiomed announces q2 fy 2020 revenue of $205 million and 29.4% operating margin

Abiomed announces q2 fy 2020 revenue of $205 million and 29.4% operating margin.sees fy 2020 revenue $885 million to $925 million.q2 revenue $205 million versus refinitiv ibes estimate of $206.4 million.q2 gaap earnings per share $0.28.q2 earnings per share estimate $0.93 -- refinitiv ibes data.maintaining its fiscal year 2020 guidance for gaap operating margin to be in range of 28% to 30%.
ABMD Ratings Summary
ABMD Quant Ranking